We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ranbaxy to Pay $2.3 Million in Oregon for Poor GMP Compliance
Ranbaxy to Pay $2.3 Million in Oregon for Poor GMP Compliance
Indian generics maker Ranbaxy will pay $2.3 million for selling drugs in Oregon that were manufactured in violation of current good manufacturing practices.